Disease activity assessment in ankylosing spondylitis in a Chinese cohort: BASDAI or ASDAS?

被引:0
作者
Yuen Ling Elaine Au
Woon Sing Raymond Wong
Mo Yin Mok
Ho Yin Chung
Eric Chan
Chak Sing Lau
机构
[1] Queen Mary Hospital,Division of Rheumatology and Clinical Immunology, University Department of Medicine
[2] Queen Mary Hospital,Division of Clinical Immunology, Department of Pathology
来源
Clinical Rheumatology | 2014年 / 33卷
关键词
Ankylosing spondylitis; ASDAS; BASDAI; Disease activity; Patient global assessment; Physician global assessment;
D O I
暂无
中图分类号
学科分类号
摘要
Recently, the Ankylosing Spondylitis Disease Activity Score (ASDAS), a new index, has been shown to be validated and highly discriminatory in assessing ankylosing spondylitis (AS) disease activity. This study is to evaluate the performance of ASDAS in a local Chinese cohort of AS in a cross-sectional setting and to compare it with the existing instrument, the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI). Consecutive patients with AS were recruited from a local rheumatology clinic. Data, including BASDAI, Bath Ankylosing Spondylitis Functional Index (BASFI), Visual Analogue Scale (VAS) for spinal pain, and patient and physician global assessments were gathered during clinic visit. Inflammatory markers, including erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and high-sensitivity (hs)-CRP were collected. ASDAS was calculated accordingly. The discriminatory capacity of BASDAI and ASDAS was compared by: (1) standardized mean difference statistics, (2) R2 in linear regressions, and (3) area under receiver operating characteristic curve (AUC) in logistic regression models. Both ASDAS and BASDAI showed satisfactory predictive value on disease activity with reference to patient and physician global assessment. R2 in linear regression models ranged from 0.6–0.7. Both indices also demonstrated good discriminatory capacity as evidenced by a relatively high AUC (> 0.8) under the logistic regression models using either patient or physician global assessment score ≥4 and <4 as cut off of high and low disease activity status, respectively. Although we could not demonstrate significant differences in the performance between them, subgroup analysis suggested better discriminatory ability of ASDAS in the high inflammatory marker subgroup. ASDAS and BASDAI showed similarly good performance in a cross-sectional setting in a local Chinese AS cohort. ASDAS performed better in subgroup with raised inflammatory markers.
引用
收藏
页码:1127 / 1134
页数:7
相关论文
共 102 条
  • [1] Haywood KL(2005)Patient-assessed health in ankylosing spondylitis: a structured review Rheumatology (Oxford) 44 577-586
  • [2] Garratt AM(1999)Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? Rheumatology (Oxford) 38 878-882
  • [3] Dawes PT(2009)Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis Ann Rheum Dis 68 18-24
  • [4] Calin A(2009)ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis Ann Rheum Dis 68 1811-1818
  • [5] Nakache JP(2007)Evaluation of internal consistency and re-test reliability of Bath ankylosing spondylitis indices in a large cohort of adult and juvenile spondylitis patients in Taiwan Clin Rheumatol 26 1685-1691
  • [6] Gueguen A(2010)Discrimination ability of ASDAS estimating disease activity status in patients with ankylosing spondylitis Int J Rheum Dis 13 240-245
  • [7] Zeidler H(2011)Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores Ann Rheum Dis 70 47-53
  • [8] Mielants H(1986)Lack of correlation between clinical disease activity and erythrocyte sedimentation rate, acute phase proteins or protease inhibitors in ankylosing spondylitis Br J Rheumatol 25 171-174
  • [9] Dougados M(1999)Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review J Rheumatol 26 966-970
  • [10] Lukas C(2005)Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives Rheumatology (Oxford) 44 789-795